Patent · US Active

Diaza-spiro[5.5]undecanes

US8530648B2 · kind B2 · utility

3Cited by

3References

13Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Sangamesh Badiger · Bengaluru, IN
Dirk Behnke · Weil am Rhein, DE
Claudia Betschart · Basel, CH
Vinod Chaudhari · Savanuru, IN
Simona Cotesta · Basel, CH
Jürgen Hans-Hermann Hinrichs · Schopfheim, DE
Silvio Ofner · Münchenstein, CH
Chetan Pandit · Edmonton, CA
Jurgen Wagner · Bottmingen, CH

Key dates

Filing date	Dec 20, 2010
Grant date	Sep 10, 2013
Priority date	—
Expiry date	Dec 20, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to compound of the formula (I), in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.